Jena Shaw Tronieri, Ph.D.

faculty photo
Assistant Professor of Psychiatry at the Hospital of the University of Pennsylvania
Director of Clinical Services, Center for Weight and Eating Disorders, Department of Psychiatry, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA
Department: Psychiatry
Graduate Group Affiliations

Contact information
Center for Weight and Eating Disorders
Department of Psychiatry
Perelman School of Medicine
at the University of Pennsylvania
3535 Market St., 3rd floor
Philadelphia, PA 19104
Office: 215-746-5045
BA (Anthropology, Spanish)
Franklin & Marshall College, 2005.
MS (Clinical Psychology)
Drexel University, 2012.
PhD (Clinical Psychology)
Drexel University, 2015.
Permanent link
> Perelman School of Medicine   > Faculty   > Details

Description of Clinical Expertise

In her clinical work, Dr. Tronieri provides behavioral weight control therapy in both individual and groups settings and conducts behavioral assessments of patients seeking bariatric surgery. She also uses evidence-based treatments including cognitive therapy and Acceptance and Commitment Therapy to treat patients with eating disorders or with comorbid anxiety or depression.

Description of Research Expertise

Dr. Tronieri’s research focuses on identifying individual predictors of weight loss success and improving weight outcomes for patients with obesity. She is also interested in evaluating acceptance-based treatments for weight and eating disorders and in bariatric surgery outcomes.

Selected Publications

Casiraghi E, Wong R, Hall M, Coleman B, Notaro M, Evans MD, Tronieri JS, Blau H, Laraway B, Callahan TJ, Chan LE, Bramante CT, Buse JB, Moffitt RA, Sturmer T, Johnson SG, Shao YR, Reese J, Robinson PN, Paccanaro A, Valentini G, Huling JD, Wilkins KJ; N3C Consoritium: A method for comparing multiple imputation techniques: A case study on the U.S. national COVID cohort collaborative. J Biomed Inform 139: 104295, Mar 2023 Notes: DOI: 10.1016/j.jbi.2023.104295.

Reddy NV, Yeh H-C, Tronieri JS, Stürmer T, Buse JB, Reusch JE, Johnson SG, Wong R, Moffitt R, Wilkins KJ, Harper J, and Bramante CT; N3C and RECOVER Consortiums: Are fewer cases of diabetes mellitus diagnosed in the months after SARS-CoV-2 infection? A population-level view in the EHR-based RECOVER program. Journal of Clinical and Translational Science 7, Feb 2023 Notes: DOI: 10.1017/cts.2023.34.

Tronieri JS, Nadolsky K, Agarwal M: Combined lifestyle interventions. Viceral and Ectopic Fat: Risk Factors for Type 2 Diabetes, Atherosclerosis, and Cardiovascular Disease. Lamb, HJ (eds.). Elsevier Inc. 1, 2023 Notes: Ch 23.

Chao AM, Tronieri JS, Amaro A, Wadden TA: Clinical insight on semaglutide for chronic weight management in adults: Patient selection and special considerations. Drug Design, Development and Therapy 16: 4449-4461, Dec 2022 Notes: doi: 10.2147/DDDT.S365416.

Bramante CT, Johnson SG, Garcia V, Evans MD, Harper H, Wilkins KJ, Huling JD, Hemalkumar M, Alexander C, Tronieri J, Hong S, Kahkoska A, Alamgir J, Koraishy F, Hartman K, Yang K, Abrahamnsen T, Sturmer T, Buse JB; N3C Consortium: Diabetes medications and associations with Covid-19 outcomes in the N3C database: A national retrospective cohort study. PLOS One 17(11), Nov 2022 Notes: DOI: 10.1371/journal.pone.0271574.

Tronieri JS, Alamuddin N, Wadden TA: Behavioral approaches to obesity management Endotext [Internet] Feingold KR, Anawalt B, Blackman MR, Boyce A, Chrousos G, et al. (eds.). South Dartmouth (MA):, Inc, Oct 2022.

Wong R, Vaddavalli R, Hall MA, Patel MV, Bramante CT, Casarighi E, Johnson SG, Lingam V, Miller JD, Reusch J, Saltz M, Stürmer T, Tronieri JS, Wilkins KJ, Buse JB, Saltz J, Huling JD, Moffitt R, N3C Consortium: Effect of SARS-CoV-2 infection and infection severity on longer-term glycemic control and weight in people with type 2 diabetes. Diabetes Care 45(11): 2709-2717, Aug 2022 Notes: DOI: 10.2337/dc22-0730.

Allison KC, Chao AM, Bruzas MB, McCuen-Wurst C, Jones E, McAllister C, Gruber K, Berkowitz RI, Wadden TA, Tronieri JS: A pilot randomized controlled trial of liraglutide 3.0 mg for binge eating disorder. Obesity Science & Practice 9(2): 127-136, Jul 2022 Notes: DOI: 10.1002/osp4.619.

Chao AM, Abenel J, Allison KC, Pearl RL, Wadden TA, Williams NN, Tronieri JS : Binge eating disorder and eating self-efficacy in adults seeking bariatric surgery. Clinical Obesity 12(4): e12531, May 2022 Notes: e12531. DOI: 10.1111/cob.12531.

Bruzas MB, Tronieri JS, Chao AM, Jones E, McAllister C, Gruber K, McCuen-Wurst C, Berkowitz RI, Wadden TA, Allison KC: Binge size and loss of control as correlates of eating behavior and psychopathology among individuals with binge eating disorder and overweight. Journal of Behavioral Medicine 45: 603–612, Apr 2022 Notes: DOI: 10.1007/s10865-022-00312-7.

back to top
Last updated: 05/24/2023
The Trustees of the University of Pennsylvania